1. Home
  2. BBIO vs FR Comparison

BBIO vs FR Comparison

Compare BBIO & FR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • FR
  • Stock Information
  • Founded
  • BBIO 2015
  • FR 1993
  • Country
  • BBIO United States
  • FR United States
  • Employees
  • BBIO N/A
  • FR N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • FR Real Estate Investment Trusts
  • Sector
  • BBIO Health Care
  • FR Real Estate
  • Exchange
  • BBIO Nasdaq
  • FR Nasdaq
  • Market Cap
  • BBIO 6.7B
  • FR 6.6B
  • IPO Year
  • BBIO 2019
  • FR 1994
  • Fundamental
  • Price
  • BBIO $33.02
  • FR $53.90
  • Analyst Decision
  • BBIO Strong Buy
  • FR Buy
  • Analyst Count
  • BBIO 12
  • FR 12
  • Target Price
  • BBIO $52.64
  • FR $58.50
  • AVG Volume (30 Days)
  • BBIO 2.7M
  • FR 1.3M
  • Earning Date
  • BBIO 05-01-2025
  • FR 04-16-2025
  • Dividend Yield
  • BBIO N/A
  • FR 3.30%
  • EPS Growth
  • BBIO N/A
  • FR 4.83
  • EPS
  • BBIO N/A
  • FR 2.17
  • Revenue
  • BBIO $221,902,000.00
  • FR $672,180,000.00
  • Revenue This Year
  • BBIO $12.42
  • FR $9.81
  • Revenue Next Year
  • BBIO $123.19
  • FR $7.93
  • P/E Ratio
  • BBIO N/A
  • FR $24.84
  • Revenue Growth
  • BBIO 2285.27
  • FR 8.73
  • 52 Week Low
  • BBIO $21.62
  • FR $45.10
  • 52 Week High
  • BBIO $39.47
  • FR $58.17
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 45.09
  • FR 42.21
  • Support Level
  • BBIO $35.77
  • FR $53.27
  • Resistance Level
  • BBIO $37.06
  • FR $54.98
  • Average True Range (ATR)
  • BBIO 1.46
  • FR 1.07
  • MACD
  • BBIO -0.01
  • FR -0.21
  • Stochastic Oscillator
  • BBIO 23.60
  • FR 20.51

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About FR First Industrial Realty Trust Inc.

First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. First Industrial's real estate portfolio is comprised of light industrial properties, which are split between industrial and office space, and bulk warehouse properties generally located in business parks near transportation hubs. While light industrial buildings represent a share of First Industrial's holdings, bulk warehouses make up the majority of its portfolio's square footage. The company derives the vast majority of its revenue from rental income tied to medium-term leases. First Industrial's customers include manufacturing, retail, wholesale trade, distribution, and professional services companies.

Share on Social Networks: